{
    "clinical_study": {
        "@rank": "73904", 
        "acronym": "OTLT", 
        "arm_group": [
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Placebo Comparator", 
                "description": "38 patients Will receive standard oral diet 3 days pefore the operation will receive placebo lipid supplementation 3 days before the operation with low omega 3 contents (Intralipid 10%)) Will receive same lipid supplementation for 5 days postoperatively"
            }, 
            {
                "arm_group_label": "OMEGA_PRE", 
                "arm_group_type": "Active Comparator", 
                "description": "38 patients Will receive standard oral diet 3 days pefore the operation will receive lipid supplementation 3 days before the operation with omega 3 enriched lipid emulsion (SMOFlipid) Will receive omega 3 enriched lipid emulsion (SMOFlipid) supplementation for 5 days postoperatively"
            }, 
            {
                "arm_group_label": "OMEGA_POST", 
                "arm_group_type": "Active Comparator", 
                "description": "38 patients Will receive standard oral diet 3 days pefore the operation will receive lipid supplementation 3 days before the operation with low omega 3 containing lipid emulsion (intralipid 10%) Will receive omega 3 enriched lipid emulsion (SMOFlipid 20%) supplementation for 5 days postoperatively"
            }
        ], 
        "brief_summary": {
            "textblock": "The study Aims to investigate the possible benfecial impact of Omega 3 containing lipid\n      emulsions on recepients for living donor liver transplantation. both perioperative and\n      postoperative application of the study treatment are tested to determine the best time for\n      drug adminstration."
        }, 
        "brief_title": "Omega 3 Lipid Emulsions and Liver Transplantation", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Reduction of Graft IR With Pretreatment of Omega 3", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All liver transplant recepients\n\n        Exclusion Criteria:\n\n          -  Budd chiarri\n\n          -  Previous upper abdominal surgery\n\n          -  Retransplantation\n\n          -  Known allergy to the study emulsion"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "114", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01957943", 
            "org_study_id": "LTX_SMOF_PRE_Eg"
        }, 
        "intervention": {
            "arm_group_label": [
                "OMEGA_PRE", 
                "OMEGA_POST"
            ], 
            "intervention_name": "SMOFLipid", 
            "intervention_type": "Dietary Supplement", 
            "other_name": "Omega 3 lipid emulsions"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Omega 3", 
            "Liver transplantation", 
            "Ischemia reperfusion", 
            "graft function"
        ], 
        "lastchanged_date": "October 4, 2013", 
        "location": {
            "contact": {
                "email": "amryassen@hotmail.com", 
                "last_name": "Amr M Yassen, MD", 
                "phone": "+201001497044"
            }, 
            "contact_backup": {
                "email": "welsarraf@yahoo.com", 
                "last_name": "waleed R elsarraf, MD", 
                "phone": "+201222322727"
            }, 
            "facility": {
                "address": {
                    "city": "Mansoura", 
                    "country": "Egypt", 
                    "state": "Dakahlia", 
                    "zip": "35511"
                }, 
                "name": "Liver transplantation program - Gastroenterology surgical center - Mansoura university"
            }, 
            "investigator": {
                "last_name": "Fawzia Abo elfetouh, MD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_arms": "3", 
        "official_title": "Impact of Pre-treatment of Living-donor Liver Transplant Recipients With Omega 3 Enriched Lipid Emulsions on Graft and Patient Outcome. A Prospective, Randomized, Multi-central Trial.", 
        "other_outcome": [
            {
                "measure": "mortality", 
                "safety_issue": "No", 
                "time_frame": "28 days"
            }, 
            {
                "measure": "Renal functions", 
                "safety_issue": "No", 
                "time_frame": "28 days"
            }, 
            {
                "measure": "Infection", 
                "safety_issue": "No", 
                "time_frame": "28 days"
            }, 
            {
                "measure": "lenght of hospital stay", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }
        ], 
        "overall_contact": {
            "email": "amryassen@hotmail.com", 
            "last_name": "Amr M Yassen, Md", 
            "phone": "+201001497044"
        }, 
        "overall_contact_backup": {
            "email": "welsarraf@yahoo.com", 
            "last_name": "Waleed R Elsarraf, MD", 
            "phone": "+201222322727"
        }, 
        "overall_official": [
            {
                "affiliation": "Mansoura University", 
                "last_name": "Amr M Yassen, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Cairo University", 
                "last_name": "Fawzia Abo elfetouh, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Egypt: Mansoura faculty of medicine", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Ischemia reperfusion injury", 
            "safety_issue": "No", 
            "time_frame": "5 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01957943"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Mansoura University", 
            "investigator_full_name": "Amr Mohamed Yassen", 
            "investigator_title": "Professor Doctor Amr M. Yassen", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Liver functions", 
            "safety_issue": "No", 
            "time_frame": "5 days"
        }, 
        "source": "Mansoura University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mansoura University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}